"Our fixed-price, fastest DNA-to-IND program is packaged in a standardized platform to allow clients to bring a new antibody molecule to IND filing in a rapid amount of time."
"The focus of our integrated Translational Pharmaceutics programs is to provide the customer with a development platform capable of responding in real-time to emerging development data and maintain an overall timeline to proof of concept."
Featuring insights from over 70 mining industry leaders, the Ontario Mining and Toronto's Global Reach 2025 pre-release edition provides a panoramic view of this ever-changing sector, shining light on the most compelling mining stories from snowy Sudbury to the green hills of Guyana.